UNSPSC 85882606: Nonimaging nuclear medicine uptake of thyroid gland using iodine 123 (i-123)

This classification denotes the group of activities that yields an intervention or procedure of nonimaging nuclear medicine uptake of thyroid gland using iodine 123 (i-123). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code CG42FZZ

UNSPSC 85882606 Nonimaging nuclear medicine uptake of thyroid gland using iodine 123 (I-123) is a Commodity code that shows little relevant recent activity in state and local procurement. The three most recent opportunities tagged under this code—a diagnostic imaging PACS system procurement, a special education contracted services RFP, and a temporary health professional staffing qualification vehicle—do not align with nuclear medicine imaging services or thyroid-specific diagnostic procedures. The code's nominal scope appears disconnected from the actual work being solicited by state and local health systems and school districts in the current marketplace.

San Mateo Medical Center, Santa Clara County Health System, and Birdville Independent School District posted these opportunities between July and October 2026, but none requested nuclear medicine uptake procedures, thyroid imaging, iodine radiopharmaceuticals, or related isotopic diagnostic services. The mismatch between the code's technical specificity and the diverse clinical-staffing and IT-infrastructure procurements tagged under it suggests either miscoding in source systems or that state and local health procurement offices are not using this code to solicit radiopharmaceutical services or nuclear imaging procedures. Business development professionals should verify whether state and local nuclear medicine imaging demand routes through different codes, bundled imaging service contracts, or cooperative purchasing vehicles not surfaced in recent indexed opportunities.